Slide 1: Submission of Investor Presentation cover letter
Ref. No.: QHTL/Sec/SE/2023-24/07 April 17, 2023 The Manager, The Manager, Corporate Services, Corporate Services, BSE Limited, National Stock Exchange of India Limited, 14th Floor, P J Towers, Dalal Street, Exchange Plaza, Bandra Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Ref: Secu
Slide 2: Earnings Presentation Q4/FY23
Earnings Presentation | Q4/FY23
Slide 3: Global cybersecurity market overview
Global cybersecurity market overview Enterprise market to maintain 95%+ share, growing at 3x Within enterprise market, product segment to gain significant consumer market till 2025 share, outpacing the overall market by 5pp Global cybersecurity market ($B) Global cybersecurity market ($B) 233 225 3%
Slide 4: Rapid digitization has enhanced need for greater cybersecurity investments
Rapid digitization has enhanced need for greater cybersecurity investments Indian Mobile data usage highest in the world* Social Network Penetration - India People enrolled in the world’s largest unique digital 46.44% 50.44% 54.58% 58.31% 1.32b identity program 35.44% 29.49% Users engaged in social
Slide 5: Company at a glance
Company at a glance Experienced Management Cash Rich Growing Team Balance Sheet Enterprise Business with high customer Presence across retention rate B2C, B2B & B2G segments Market Leader Strong in the Indian Distribution Footprint retail segment across India 25+ Years of Innovation State-of-the-art
Slide 6: Over 25 years of simplifying security
Our Journey Threat Secured protection for smart Innovative AI PCs, phones driven network and tablets Protecting protection & emails Protected Ensured data, early a safe transactions generations online & cloud of PCs experience transitions 1993-95 1996-00 2001-05 2006-10 2011-16 2017-23 Over 25 years
Slide 7: The Cash Cow: Retail Anti Virus Business
The Cash Cow: Retail Anti Virus Business ▪ Over 25 years into existence ▪ Market leadership with over 30% in the Indian market ▪ Robust Sales & Distribution network in India Revenue (INR Crs) 293 Current Scenario: 280 30 242 ▪ Market Headwinds in the short term: Sudden decrease in IT 198 spending si
Slide 8: The Growth Story: Enterprise Solutions
The Growth Story: Enterprise Solutions ▪ Incubated the enterprise cybersecurity through internal accruals ▪ Growth story for QH in the years to come ▪ Enterprise solutions represent 95% of the cybersecurity market, which is growing at a CAGR of 11% while Quick Heal is growing at 21% Business Momentu
Slide 9: Future Outlook
Future Outlook Strong and Diversified Increasing R&D spend Channel Network R&D team continuously With 35,000+ channel partners, working towards product sales team upgrades with newer features. Has deep market penetration In FY23 R&D spends of 44% Innovation Quick Heal lays strong Global expansion em
Slide 10: Q4/FY23 Earnings Highlights
Q4/FY23 EARNINGS HIGHLIGHTS
Slide 11: Q4-FY23 Earnings Highlights
Q4-FY23 Earnings Highlights REVENUE EBITDA PAT Q4-FY23Revenue split Q4-FY23 Revenue at Q4-FY23 EBITDA at Q4-FY23 PAT at ₹ 49.3 crs ₹ (16.2) crs ₹ (6.6) crs Down 52% YoY Down 146% YoY Down 124% YoY 45.6% 54.4% DILUTED EPS RETAIL REVENUE ENTERPRISE REVENUE Q4-FY23 EPS at Q4-FY23 Retail revenue at Q4-F
Slide 12: FY23 Earnings Highlights
FY23 Earnings Highlights REVENUE EBITDA PAT FY23Revenue split FY23 Revenue at FY23 EBITDA at FY23 PAT at ₹ 278.1 crs ₹ 1.9 crs ₹ 6.4 crs 35.1% Down 19% YoY Down 98% YoY Down 92% YoY 64.9% DILUTED EPS RETAIL REVENUE ENTERPRISE REVENUE FY23 EPS at FY23 Retail revenueat FY23 Enterprise revenueat ₹ 1.14
Slide 13: Q4/FY23 Consolidated Performance Highlights
Q4/FY23 Consolidated Performance Highlights Revenue (INR Crs) EBIDTA (INR Crs) PAT (INR Crs) EBITDA and PAT Margin (%) -52% -146% -124% 103.7 34.9 28.1 33.63% 27.10% 49.3 Q4-FY22 Q4-FY23 - - 13.47% 32.81% Q4FY22 Q4FY23 -16.2 -6.6 EBITDA Margin PAT Margin Q4FY22 Q4FY23 Q4FY22 Q4FY23 Revenue (INR Crs)
Slide 14: Working Capital Analysis
Working Capital Analysis 143 5 133 5 38 34 114 5 110 104 25 94 Receivable Inventory Payable Net Receivable Inventory Payable Net Receivable Inventory Payable Net Days Days Days Working Days Days Days Working Days Days Days Working Capital Capital Capital Q4FY22 Days Q3FY23 Days Q4FY23 Days • Calcula
Slide 15: Q4-FY23 Income Statement
Q4-FY23 Income Statement Standalone Consolidated PARTICULARS (₹ crs) Q4-FY22 Q4-FY23 % change Q4-FY22 Q4-FY23 % change Total Revenue 103.75 49.29 -52.49% 103.71 49.28 -52.48% Direct Cost 4.78 1.57 4.81 1.57 Gross Profit 98.97 47.72 -51.78% 98.90 47.71 -51.76% Gross Margin 95.39% 96.81% 95.36% 96.81%
Slide 16: FY23 Income Statement
FY23 Income Statement Standalone Consolidated PARTICULARS (₹ crs) FY22 FY23 % change FY22 FY23 % change Total Revenue 341.55 278.11 -18.57% 341.90 278.09 -18.66% Direct Cost 14.09 10.31 13.84 10.31 Gross Profit 327.46 267.80 -18.22% 328.06 267.78 -18.38% Gross Margin 95.87% 96.29% 95.95% 96.29% Oper
Slide 17: Q4-FY23 Ratio analysis
Q4-FY23 Ratio analysis Standalone Consolidated In % Q4FY22 Q4-FY23 Q4-FY22 Q4-FY23 Expenses Direct Cost / Revenue 4.61% 3.19% 4.64% 3.19% R&D / Revenue 27.10% 62.45% 27.12% 62.46% S&M / Revenue 21.27% 47.45% 21.60% 47.46% G&A / Revenue 13.62% 19.33% 13.00% 19.71% Total Cost / Revenue 61.99% 129.24%
Slide 18: FY23 Ratio analysis
FY23 Ratio analysis Standalone Consolidated In % FY22 FY23 FY22 FY23 Expenses Direct Cost / Revenue 4.13% 3.71% 4.05% 3.71% R&D / Revenue 26.58% 43.62% 26.55% 43.62% S&M / Revenue 23.78% 33.23% 24.11% 33.24% G&A / Revenue 14.53% 18.44% 14.03% 18.76% Total Cost / Revenue 64.89% 95.29% 64.69% 95.62% M
Slide 19: Historical Annual Consolidated Income Statement
Historical Annual Consolidated Income Statement PARTICULARS (INR Crs) FY21 FY22 FY23 Total Revenue 333.04 341.90 278.09 Direct Cost 13.70 13.84 10.31 Gross Profit 319.34 328.06 267.78 Gross Margins (%) 95.89% 95.95% 96.29% Operating Cost Total Expenditure 177.90 221.20 265.90 EBITDA 141.44 106.86 1.
Slide 20: Consolidated Balance Sheet
Consolidated Balance Sheet EQUITY AND LIABILITIES (` Crs) March 31, 2022 March 31, 2023 ASSETS (` Crs) March 31, 2022 March 31, 2023 Share Holder's Funds: Non-Current Assets: Equity Share Capital 58.01 53.07 Property, plant and equipment 105.93 97.56 Reserves and Surplus 569.62 366.64 Capital work-i
Slide 21: Standalone Balance Sheet
Standalone Balance Sheet EQUITY AND LIABILITIES (` Crs) March 31, 2022 March 31, 2023 ASSETS (` Crs) March 31, 2022 March 31, 2023 Share Holder's Funds: Non-Current Assets: Equity Share Capital 58.01 53.07 Property, plant and equipment 105.94 97.57 Reserves and Surplus 569.20 366.65 Capital work-in-
Slide 22: Capital Market Data
Capital Market Data Stock Market Performance (as on 31st March, 2023) 16% 8% 0% -8% -16% Shareholding Pattern (as on 31st March, 2023) -24% -32% -40% Apr-22 May-22 Jun-22 Jul-22 Aug-22 Sep-22 Oct-22 Nov-22 Dec-22 Jan-23 Feb-23 Mar-23 Public 22% Sensex Quick Heal-BSE Others Price Data (as of 31st Mar
Slide 23: Disclaimer
Disclaimer Quick Heal Technologies Limited No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness, or correctness of the information or opinions contained in this presentation. Such information and opinions are in a
Slide 24: Thank You
Thank You